Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Trial of Outpatient Oxygen Weaning Strategies in Premature Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infant with birth gestational age ≤ 37 (37 0/7) wks postmenstrual age (PMA) who has requirement for supplemental O2 at time of NICU discharge, as determined by primary NICU team.~* Infant receiving pediatric pulmonology care at the Center for Healthy Infant Lung Development~* Parent aged 18 years or older~* English or Spanish-speaking.~Exclusion Criteria:~* Parents whose infants has presence of pulmonary hypertension at enrollment~* Parents whose infant with syndrome or other diagnosis with known high risk for persistent hypoxia (cardiac disease, Trisomy 21, Pierre-Robin Sequence, etc.)~* Parents whose infant has requirement for O2 flow rate \> 1 L/min or tracheostomy~* Any infants who also require caffeine at discharge from the NICU

- Gender: ALL
- Minimum Age: None
- Maximum Age: 37 Weeks
- Healthy Volunteers: f

Study Arms:
- Arm A:Standard therapy (Type: NO_INTERVENTION): Infants' oxygen will be increased, decreased, or maintained based on brief structured assessments during monthly clinic visits. Polysomnograms will be utilized prior to final discontinuation of oxygen. RHO will only be utilized on the night prior to and during the polysomnogram to compare these two modalities.
- Arm B:RHO (Type: EXPERIMENTAL): Infants will have the same monthly clinic assessments as in Arm A, but also will utilize RHO to potentially increase, decrease or maintain oxygen between monthly visits.~Parents will transmit a minimum of 4 days of stored RHO data (min 8 hrs per day) every 4-7 days. Changes in oxygen needs will be made based on standardized objective criteria. To determine discontinuation of oxygen, RHO will be utilized instead of polysomnography.

Based on this trial design, predict the completion outcome and termination type (if applicable).